Harel Insurance Investments & Financial Services Ltd. Takes $115,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 382 shares of the company’s stock, valued at approximately $115,000.

Several other large investors have also modified their holdings of HCA. Exchange Traded Concepts LLC grew its position in shares of HCA Healthcare by 57.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 1,608 shares of the company’s stock worth $483,000 after acquiring an additional 585 shares in the last quarter. CX Institutional increased its stake in HCA Healthcare by 16.2% during the fourth quarter. CX Institutional now owns 15,707 shares of the company’s stock valued at $4,715,000 after purchasing an additional 2,185 shares during the last quarter. Berbice Capital Management LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $78,000. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $1,021,000. Finally, Red Door Wealth Management LLC grew its holdings in shares of HCA Healthcare by 1.5% during the fourth quarter. Red Door Wealth Management LLC now owns 21,659 shares of the company’s stock valued at $6,501,000 after purchasing an additional 321 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HCA. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. TD Cowen decreased their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Oppenheimer boosted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Price Performance

NYSE HCA opened at $312.51 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a market capitalization of $79.16 billion, a P/E ratio of 14.03, a P/E/G ratio of 1.09 and a beta of 1.64. The business’s fifty day moving average is $313.49 and its two-hundred day moving average is $352.62. HCA Healthcare, Inc. has a 1 year low of $279.93 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the firm posted $5.90 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 21.75 earnings per share for the current fiscal year.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.